Nome Químico: N-(2,6-Dimethylphenyl)-1-methylpiperidine-2-carboxamide
Sorrisos: CC1=C(NC(C2N(C)CCCC2)=O)C(C)=CC=C1
Inchi: InChI=1S/C45H51N7O7S/c1-45(2)16-12-34(39(27-45)32-6-4-3-5-7-32)30-50-18-20-51(21-19-50)35-8-10-38(42(25-35)59-36-24-33-13-17-46-43(33)48-29-36)44(53)49-60(56,57)37-9-11-40(41(26-37)52(54)55)47-28-31-14-22-58-23-15-31/h3-11,13,17,24-26,29,31,47H,12,14-16,18-23,27-28,30H2,1-2H3,(H,46,48)(H,49,53)
Simultaneous determination of bupivacaine, mepivacain, prilocaine and ropivacain in human serum by liquid chromatography–tandem mass spectrometry
A. Koehler ∗, R. Oertel, W. Kirch
Journal of Chromatography A, 1088 (2005) 126–130
Racemisation of R-Bupivacaine: A Key Factor in the Integrated and Economic Process for the Production of Levobupivacaine
Marianne Langston,* Ulrich C. Dyer,† Graham A. C. Frampton, Gordon Hutton,‡ Christopher J. Lock, Benjamin M. Skead, Martin Woods,§ and Hooshang S. Zavareh
Organic Process Research & Development 2000, 4, 530−533
Investigation into spinal anesthetic failure with hyperbaric bupivacaine: the role of cold exposure on bupivacaine degradation
Ellen K. Wasan PhD, Calen Sacevich MD, Anas El-Aneed PhD, Munawar Mohammed MSc, Jaweria Syeda MPharm, Erin Neville BSP, Tatiana Orlowski, David Campbell MD & Jonathan Gamble MD
Canadian Journal of Anesthesia/Journal canadien d'anesthésie volume 66, pages803–812(2019)